Rosana Kapeller

Rosana Kapeller has over 15 years leadership experience in the biotechnology industry. Prior to joining Nimbus, she was Vice President, Research and Co-Founder of Aileron Therapeutics. From 2005 to 2009, Dr. Kapeller led the development of Aileron’s “Stapled Peptide” technology and the first stapled-peptide development candidate. Under her scientific leadership, Aileron secured $60 million in venture financing over its first 4 years.

Prior to co-founding Aileron, Dr. Kapeller held positions of increasing responsibility at Millennium Pharmaceuticals most recently serving as Director, Department of Molecular and Cellular Biology.

Rosana earned her M.D. from Rio de Janeiro State University in Brazil, and her Ph.D. from Tufts University Medical School, where she trained with Dr. Lewis C. Cantley.

She conducted her post-doctoral research work at the Dana-Farber Cancer Institute where she was named a David Abraham Fellow in Pediatric Oncology.

Rosana Kapeller is the Co-founder, President and CEO at ROME Therapeutics, based in United States, North America. With a background in Biotechnology, Rosana Kapeller has a rich history of leadership and innovation.Rosana Kapeller studied MD unknown at UERJ. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.